Chlorinated lipid species in activated human neutrophils: Lipid metabolites of 2-chlorohexadecanal

Journal of Lipid Research

Volumn 51, Issue 5, 2010, Pages 1085-1092

  Anbukumar, Dhanalakshmi S ^a,b   Shornick, Laurie P ^b   Albert, Carolyn J ^a,b   Steward, Melissa M ^a,b   Zoeller, Raphael A ^c   Neumann, William L ^d   Ford, David A ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROHEXADECANAL; 2 CHLOROHEXADECANOIC ACID; 2 CHLOROHEXADECANOL; ALDEHYDE DEHYDROGENASE; DECANOIC ACID; HEXADECANOL; MYELOPEROXIDASE; PALMITIC ACID DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMALOGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHIOLITIS; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SENDAI VIRUS;

ALDEHYDES; ANIMALS; BRONCHOALVEOLAR LAVAGE; CHO CELLS; CRICETINAE; CRICETULUS; FATTY ALCOHOLS; HALOGENATION; HUMANS; LIPID METABOLISM; MICE; NEUTROPHILS; PHORBOL ESTERS; RESPIRATORY TRACT INFECTIONS;

EID: 77951049074     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M003673     Document Type: Article

References (39)

1. Daugherty, A., J. L. Dunn, D. L. Rateri, and J. W. Heineke. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesion. J. Clin. Invest. 94: 437-444. (Pubitemid 24218123)
2. Klebanoff, S. J. 1980. Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 93: 480-489.
3. Weiss, J., M. Victor, O. Stendhal, and P. Elsbach. 1982. Killing of gram-negative bacteria by polymophonuclear leukocytes: role of an O 2 -independent bacterial system. J. Clin. Invest. 69: 959-970. (Pubitemid 12149173)
4. Harrison, J. E., and J. Schultz. 1976. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251: 1371-1374.
5. Klebanoff, S. J., A. M. Waltersdorph, and H. Rosen. 1984. Antimicrobial activity of myeloperoxidase. Methods Enzymol. 105: 399-403.
6. Albrich, J. M., C. A. McCarthy, and J. K. Hurst. 1981. Biological reactivity of hypochlorous acid: implications for microbicidal mechanisms of leukocyte myeloperoxidase. Proc. Natl. Acad. Sci. USA. 78: 210-214.
7. Weiss, S. J., R. Klein, A. Slivka, and M. Wei. 1982. Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation. J. Clin. Invest. 70: 598-607.
8. Thomas, E. L., M.M. Jefferson, and M.B. Grisham. 1982. Myeloperoxidase-catalyzed incorporation of amines into proteins: role of hypochlorous acid and dichloramines. Biochemistry. 21: 6299-6308.
9. Winterbourn, C. C., J. J. van den Berg, E. Roitman, and F. A. Kuypers. 1992. Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch. Biochem. Biophys. 296: 547-555.
10. Rakita, R. M., B. R. Michel, and H. Rosen. 1990. Differential inactivation of escherichia coli membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system. Biochemistry. 29: 1075-1080.
11. Wang, Y., H. Rosen, D. K. Madtes, B. Shao, T. R. Martin, J. W. Heinecke, and X. Fu. 2007. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. J. Biol. Chem. 282: 31826-31834. (Pubitemid 350106428)
12. Carlin, G., and R. Djursäter. 1988. Peroxidation of phospholipids promoted by myeloperoxidase. Free Radic. Res. Commun. 4: 251-257.
13. Hazen, S. L., F. F. Hsu, J. P. Gaut, J. R. Crowley, and J. W. Heinecke. 1999. Modification of proteins and lipids by myeloperoxidase. Methods Enzymol. 300: 88-105.
14. Albert, C. J., J. R. Crowley, F. F. Hsu, A. K. Thukkani, and D. A. Ford. 2001. Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal. J. Biol. Chem. 276: 23733-23741. (Pubitemid 37410768)
15. Thukkani, A. K., J. McHowat, F. F. Hsu, M. L. Brennan, S. L. Hazen, and D. A. Ford. 2003. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation. 108: 3128-3133.
16. Wildsmith, K. R., C. J. Albert, D. S. Anbukumar, and D. A. Ford. 2006. Metabolism of myeloperoxidase-derived 2-chlorohexadecanal. J. Biol. Chem. 281: 16849-16860.
17. Rizzo, W. B., D. A. Craft, A. L. Dammann, and M. W. Phillips. 1987. Fatty alcohol metabolism in cultured human fibroblasts. Evidence for a fatty alcohol cycle. J. Biol. Chem. 262: 17412-17419. (Pubitemid 18032217)
18. Thukkani, A. K., F. F. Hsu, J. R. Crowley, R. B. Wysolmerski, C. J. Albert, and D. A. Ford. 2002. Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens: production of the chemoattractant, 2-chlorohexadecanal. J. Biol. Chem. 277: 3842-3849.
19. James, P. F., and R. A. Zoeller. 1997. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sjogren-Larsson syndrome. J. Biol. Chem. 272: 23532-23539.
20. + oxidoreductase activity. Proc. Natl. Acad. Sci. USA. 87: 6102-6106.
21. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
22. Ferrante, A., and Y. H. Thong. 1980. Simultaneous preparation of mononuclear and polymorphonuclear leucocytes from horse blood on ficoll-hypaque medium. J. Immunol. Methods. 34: 279-285. (Pubitemid 10065193)
23. Zigmond, S. H., and J. G. Hirsch. 1973. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 137: 387-410.
24. Shornick, L. P., A. G. Wells, Y. Zhang, A. C. Patel, G. Huang, K. Takami, M. Sosa, N. A. Shukla, E. Agapov, and M. J. Holtzman. 2008. Airway epithelial versus immune cell stat1 function for innate defense against respiratory viral infection. J. Immunol. 180: 3319-3328.
25. Suganami, T., J. Nishida, and Y. Ogawa. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 25: 2062-2068. (Pubitemid 41416301)
26. Bradley, P. P., D. A. Priebat, R. D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78: 206-209.
27. Curzio, M., H. Esterbauer, C. Di Mauro, G. Cecchini, and M. U. Dianzani. 1986. Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals. Biol. Chem. Hoppe Seyler. 367: 321-329. (Pubitemid 16107430)
28. Curzio, M., C. Di Mauro, H. Esterbauer, and M. U. Dianzani. 1987. Chemotactic activity of aldehydes. Structural requirements. Role in inflammatory process. Biomed. Pharmacother. 41: 304-314. (Pubitemid 18016792)
29. Rizzo, W. B., E. Heinz, M. Simon, and D. A. Craft. 2000. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjogren-Larsson syndrome. Biochim. Biophys. Acta. 1535: 1-9.
30. Rizzo, W. B. 1993. Sjogren-Larsson syndrome. Semin. Dermatol. 12: 210-218.
31. + oxidoreductase in cultured fibroblasts. J. Clin. Invest. 88: 1643-1648.
32. Wildsmith, K. R., C. J. Albert, F. F. Hsu, J. L. Kao, and D. A. Ford. 2006. Myeloperoxidase-derived 2-chlorohexadecanal forms schiff bases with primary amines of ethanolamine glycerophospholipids and lysine. Chem. Phys. Lipids. 139: 157-170.
33. Hawley, H. P., and G. B. Gordon. 1976. The effects of long chain free fatty acids on human neutrophil function and structure. Lab. Invest. 34: 216-222.
34. Bellavite, P., P. Guarani, D. Biasi, A. Carletto, M. T. Trevisan, P. Caramaschi, L. M. Bambara, and R. Corrocher. 1995. Correlations between the intensity of fMLP-dependent respiratory burst and cellular fatty acid composition in human neutrophils. Br. J. Haematol. 89: 271-276.
35. Akamatsu, H., Y. Niwa, and K. Matsunaga. 2001. Effect of palmitic acid on neutrophil functions in vitro. Int. J. Dermatol. 40: 640-643. (Pubitemid 33094502)
36. Curzio, M., M. V. Torrielli, J. P. Giroud, H. Esterbauer, and M. U. Dianzani. 1982. Neutrophil chemotactic responses to aldehydes. Res. Commun. Chem. Pathol. Pharmacol. 36: 463-476.
37. Curzio, M., H. Esterbauer, and M. U. Dianzani. 1985. Chemotactic activity of hydroxyalkenals on rat neutrophils. Int. J. Tissue React. 7: 137-142. (Pubitemid 15054766)
38. Rizzo, W. B., and D. A. Craft. 2000. Sjörgren-Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma. J. Lipid Res. 41: 1077-1081.
39. Thukkani, A. K., C. J. Albert, K. R. Wildsmith, M. C. Messner, B. D. Martinson, F. F. Hsu, and D. A. Ford. 2003. Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein. J. Biol. Chem. 278: 36365-36372.